ArticleClinical case reports2024

SGLT-2 inhibitors and high-dose acarbose as potential high-risk combinations for ketosis and ketoacidosis in Asian patients with T2DM: A case series.

Wei Qiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.